黑料网

Journal of Oncology Research and Treatment
黑料网

Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ 黑料网 Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

黑料网 Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Research Article   
  • J Oncol Res Treat ,
  • DOI: 10.4172/aot.1000200.

Anti-Tumoral Effects of Natural Killer Cells Differentiated In Vitro from Cord-Blood Hematopoietic Stem Cells on Umbilical Cord Mesenchymal Stem Cells against Glioblastoma

Ege Cubuk1*, Latife Merve Oktay2, Hilal Kabadayi Ensarioglu3, H. Seda Vatansever3,4 and Gulinnaz Ercan5,6*
1Department of Infectious Disease and Clinical Microbiology, School of Medicine, Ankara University, Ankara, Turkey
2Department of Medical Biology, Ege University, Izmir, Turkey
3Department of Histology and Embryology, Celal Bayar University, Manisa, Turkey
4DESAM Institute, Near East University, Mersin 10, Turkey
5Department of Medical Biochemistry, Ege University Medical School, Izmir, Turkey
6Department of Stem Cell, Institute of Health Sciences, Ege University, Izmir, Turkey
*Corresponding Author (s) : Ege Cubuk, Department of Infectious Disease and Clinical Microbiology, School of Medicine, Ankara University, Ankara, Turkey, Email: cubukege@gmail.com
Gulinnaz Ercan, Department of Medical Biochemistry, Ege University Medical School, Izmir, Turkey, Email: gulinnazalper@yahoo.com

Received Date: Jan 02, 2023 / Published Date: Feb 17, 2023

Abstract

Purpose: Glioblastoma is the most malignant primary adult brain tumor with a poor prognosis; therefore, novel therapies are needed. Natural Killer (NK) cells are promising candidates for immunotherapy because of their ability to eliminate tumor cells without prior sensitization. An inadequate number of NK cells remain a major obstacle. The primary purpose of this study was to develop NK cells from Cord Blood Hematopoietic Stem Cells (CB-HSCs) on Umbilical Cord Mesenchymal Stem Cells (UC-MSCs) feeder layer and analyse cytotoxic potential of NK cells against glioblastoma in vitro.

Methods: UC-MSCs were treated with mitomycin-C to be used as a feeder layer. CB-HSCs were co-cultured with UC-MSCs and differentiated into NK cells by using medium containing cytokines such as thrombopoietin, Flt3- ligand, stem cell factor, IL-6, IL-7, IL-15 and IL-2. NK cells were characterized by immunocytochemistry. The in vitro cytotoxic effect of NK cells on T98-glioblastoma cells was determined by annexin V‑fluorescein isothiocyanate/ propidium iodide staining followed by flow cytometric analysis. qRT-PCR was performed to measure gene expression levels of KRAS, TP53, TGFBR2 and NANOG in glioblastoma cells after treatment with NK cells.

Results: NK cells were successfully differentiated from CB-HSCs on the UC-MSC feeder layer with the strong expression of cytotoxic receptors after 6 weeks. They demonstrated potent cytotoxicity against glioblastoma in vitro. Additionally, the KRAS oncogene expression in glioblastoma cells decreased upon co-culture with NK cells.

Conclusion: NK cells differentiated from CB-HSCs on UC-MSC feeder-layer were capable of eliminating glioblastoma cells via apoptosis in vitro and warrant further investigation in vivo and clinical settings.

Keywords: Apoptosis; Tissues; Monocyte Chemo Attractant Protein; Brain tumor; Cancer; Immunotherapy

Citation: Cubuk E, Oktay LM, Ensarioglu HK, Vatansever SH, Ercan G (2023) Anti-Tumoral Effects of Natural Killer Cells Differentiated In Vitro from Cord-Blood Hematopoietic Stem Cells on Umbilical Cord Mesenchymal Stem Cells against Glioblastoma. J Oncol Res Treat 8:200. Doi: 10.4172/aot.1000200.

Copyright: © 2023, Cubuk E, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

International Conferences 2024-25
 
Meet Inspiring Speakers and Experts at our 3000+ Global

Conferences by Country

Medical & Clinical Conferences

Conferences By Subject

Top